Skip to main content
Clinical Trials/EUCTR2017-003144-21-NL
EUCTR2017-003144-21-NLActive, not recruitingPhase 1

Cost-effectiveness of perioperative vaginally administered oestrogen in postmenopausal women undergoing prolapse surgery. - EVA trial

Board of Directors, Academic Medical Centre0 sites300 target enrollmentStarted: February 28, 2018Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • - Postmenopausal women (>1 year amenorrhoea) with a minimum age of 18 years old
  • - Pelvic organ prolapse; POP Quantification stage 2 or higher
  • - Women that will undergo primary POP surgery with native tissue repair; including at least anterior OR posterior vaginal wall repair.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 150

Exclusion Criteria

  • - Previous POP surgery in concerning compartment
  • - Prolapse repair using mesh
  • - Current vaginal infection
  • - Use of oestrogens in the past 12 months
  • - Contraindication for use of topical oestrogen
  • - Known, past or suspected oestrogen-dependent malignant tumours (e.g. breast cancer, endometrial cancer);
  • - Insufficient knowledge or understanding of the Dutch language

Investigators

Sponsor
Board of Directors, Academic Medical Centre

Similar Trials

Research into effectiveness and costs... | Clinical Trial